BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv T, Li M, Zeng N, Zhang J, Li S, Chen S, Zhang C, Shan S, Duan W, Wang Q, Wu S, You H, Ou X, Ma H, Zhang D, Kong Y, Jia J. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol 2019;34:1676-84. [PMID: 31146297 DOI: 10.1111/jgh.14746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Inflamm Bowel Dis 2022:izac189. [PMID: 36040402 DOI: 10.1093/ibd/izac189] [Reference Citation Analysis]
2 Dong B, Chen Y, Lyu G, Yang X. Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis. Front Immunol 2022;13:892454. [PMID: 35663945 DOI: 10.3389/fimmu.2022.892454] [Reference Citation Analysis]
3 Roy A, Verma N, Singh S, Pradhan P, Taneja S, Singh M. Immune-mediated liver injury following COVID-19 vaccination: A systematic review. Hepatol Commun 2022. [PMID: 35507736 DOI: 10.1002/hep4.1979] [Reference Citation Analysis]
4 Katsumi T, Ueno Y. Epidemiology and surveillance of autoimmune hepatitis in Asia. Liver Int 2022. [PMID: 34990076 DOI: 10.1111/liv.15155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Matarazzo L, Nastasio S, Sciveres M, Maggiore G. Pregnancy outcome in women with childhood onset autoimmune hepatitis and autoimmune sclerosing cholangitis on long-term immunosuppressive treatment. Eur J Obstet Gynecol Reprod Biol 2021;268:7-11. [PMID: 34788721 DOI: 10.1016/j.ejogrb.2021.10.030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gan J, Gao Q, Wang LL, Tian AP, Zhu LD, Zhang LT, Zhou W, Mao XR, Li JF. Glucosylceramide synthase regulates hepatocyte repair after concanavalin A-induced immune-mediated liver injury. PeerJ 2021;9:e12138. [PMID: 34611503 DOI: 10.7717/peerj.12138] [Reference Citation Analysis]
7 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol 2021. [PMID: 34580437 DOI: 10.1038/s41423-021-00768-8] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Li SL, Cao R, Hu XF, Xiong P, Zhao GY, Xie YN, Wang ZM, Li YK, Yang B, Yang J. Daidzein ameliorated concanavalin A-induced liver injury through the Akt/GSK-3β/Nrf2 pathway in mice. Ann Transl Med 2021;9:1228. [PMID: 34532365 DOI: 10.21037/atm-21-378] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clin Rev Allergy Immunol 2021. [PMID: 34491531 DOI: 10.1007/s12016-021-08888-9] [Reference Citation Analysis]
10 Franceschini T, Vasuri F, Muratori P, Muratori L, Guido M, Lenzi M, D'Errico A. A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center. Virchows Arch 2021. [PMID: 34189631 DOI: 10.1007/s00428-021-03122-5] [Reference Citation Analysis]
11 Saadah OI, Khayat A, Alsufyani HA, Bin-Taleb Y. Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia. Arab J Gastroenterol 2021;22:146-50. [PMID: 34059447 DOI: 10.1016/j.ajg.2021.05.009] [Reference Citation Analysis]
12 Dalekos GN, Azariadis K, Lygoura V, Arvaniti P, Gampeta S, Gatselis NK. Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome. Liver Int 2021;41:1592-9. [PMID: 33896089 DOI: 10.1111/liv.14900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
14 He C, Yang Y, Zheng K, Chen Y, Liu S, Li Y, Han Q, Zhao RC, Wang L, Zhang F. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Ther Adv Chronic Dis 2021;12:2040622321993442. [PMID: 33633826 DOI: 10.1177/2040622321993442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kitagataya T, Suda G, Nagashima K, Katsurada T, Yamamoto K, Kimura M, Maehara O, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Umemura M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Komatsu Y, Hata H, Takeuchi S, Abe T, Sakakibara‐konishi J, Teshima T, Homma A, Sakamoto N. Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy‐associated hepatitis in Japan. Journal of Gastroenterology and Hepatology 2020;35:1782-8. [DOI: 10.1111/jgh.15041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ma L, Zhang LW, Zhuang Y, Ding YB, Chen JP. Exploration the significance of Tfh and related molecules on C57BL/6 mice model of experimental autoimmune hepatitis. J Microbiol Immunol Infect 2021;54:221-7. [PMID: 31624016 DOI: 10.1016/j.jmii.2019.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]